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IL-12 Deficiency Exacerbates Inflammatory
Responses in UV-Irradiated Skin and Skin Tumors
Syed M. Meeran1, Thejass Punathil1 and Santosh K. Katiyar1,2
IL-12 deficiency has been shown to promote photocarcinogenesis in mice. As UVB-induced inflammation is an
important tumor-promoting event in the development of skin tumors, we determined the effects of IL-12-
deficiency on UVB-induced inflammatory responses in mice. For this purpose, IL-12-knockout (IL-12 KO) and
their wild-type counterparts were subjected to a photocarcinogenesis protocol; skin and tumor samples were
collected at the termination of the experiment, and analyzed for biomarkers of inflammation and their
mediators. We found that the levels of infiltrating leukocytes, myeloperoxidase, proliferating cell-nuclear
antigen (PCNA), COX-2, PGE2, and the proinflammatory cytokines IL-1b, TNF-a, and IL-6 were higher in the UVB-
exposed skin of IL-12 KO than in that of wild-type mice. In a short-term experiment, pretreatment of IL-12 KO
mice with rIL-12 (50 ng per mouse) before each exposure to UVB increased the repair rate of UVB-induced
cyclobutane pyrimidine dimers, while inhibiting UVB-induced increases in myeloperoxidase, COX-2, PGE2,
PCNA, TNF-a, and IL-1b in the skin as compared with non-rIL-12-treated IL-12 KO mice. Similarly, tumors of IL-12
KO mice expressed higher levels of inflammatory responses than those of wild-type mice. Together, our data
suggest that IL-12 KO mice are more susceptible to both UVB-induced inflammation and photocarcinogenesis
because of the deficiency in the repair of UVB-induced DNA damage.
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INTRODUCTION
Exposure of the skin to solar UV radiation induces oxidative
stress, inflammatory responses, immunosuppression, gene
mutations, and DNA damage, which collectively have been
implicated in a variety of skin diseases, including photo-
carcinogenesis and photoaging of the skin (Kligman, 1986;
Katiyar et al., 2000, 2007; Katiyar, 2006). UV-induced
inflammatory responses characterized by increased blood
flow and vascular permeability, result in development of
edema, erythema, hyperplastic responses, and increases in
the levels of cyclooxygenase-2 (COX-2) and prostaglandin
(PG) metabolites (Black et al., 1978; Rivas and Ullrich, 1994;
Mukhtar and Elmets, 1996; Katiyar and Meeran, 2007).
Inflammation results in recruitment of infiltrating leukocytes
secreting a variety of proinflammatory cytokines at the UV-
irradiated sites, and is therefore considered an early event in
tumor promotion and/or tumor development. Chronic in-
flammation plays a crucial role in all the three stages of tumor
development, that is, initiation, promotion, and progression
(Mukhtar and Elmets, 1996).
IL-12 is an immunoregulatory cytokine composed of two
disulfide bonded protein chains p35 and p40 (Trinchieri,
1994), and has been shown to have antitumor activity in a
wide variety of tumor models (Brunda et al., 1993; Brunda,
1994; Zou et al., 1995; Robertson and Ritz, 1996). Its
presence at tumor site is critical for tumor regression
(Colombo et al., 1996). We and others have shown
previously that mice deficient in IL-12 are at higher risk of
UV radiation-induced skin tumors than their wild-type (WT)
counterparts (Maeda et al., 2006; Meeran et al., 2006). We
observed that development of UV-induced tumors in IL-12-
deficient or knockout (IL-12 KO) mice was earlier, more rapid
and tumor incidence, multiplicity, and tumor size were
significantly higher than in C3H/HeN mice, their WT
counterparts, following a photocarcinogenesis protocol
(Meeran et al., 2006). These data suggested that deficiency
of IL-12 in mice increases their susceptibility to photocarci-
nogenesis. The demonstration of significant antitumor activity
in preclinical animal tumor models has stimulated interest in
the therapeutic use of IL-12 (Nastala et al., 1994; Chen et al.,
1997; Siders et al., 1998), but our understanding of the
mechanisms underlying the antitumor activity of IL-12 in
photocarcinogenesis is not clear.
As UV-induced inflammation and its mediators have been
implicated in tumor development, we sought to determine
whether IL-12-deficiency stimulates greater inflammatory
responses in UV-exposed skin and tumors of IL-12 KO mice
as compared with their WT counterparts. As UVB-induced
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inflammatory responses, such as production of cytokines, and
UVB-induced tumorigenesis are both causally related to
UVB-induced DNA damage, we examined whether IL-12 KO
mice are more susceptible to these UVB-induced effects
because they are deficient in the repair of UVB-induced DNA
damage (cyclobutane pyrimidine dimers (CPDs)).
RESULTS
IL-12 deficiency enhances UVB-induced tumor development
and cutaneous leukocyte infiltration
As reported earlier, it was observed that IL-12-deficient mice
develop significantly higher number of tumors (Po0.001)
than their WT counterparts (Figure 1a) after exposure to a
photocarcinogenesis protocol (Meeran et al., 2006). The
number of tumors in the group of IL-12 KO mice remained
higher than the total number of tumors in the group of WT
mice throughout the experimental protocol. As UVB-induced
infiltration of leukocytes is the major source of inflammatory
reactions, we examined the effect of UVB-induced infiltration
in IL-12 KO and their WT counterparts. As shown in Figure
1b, chronic exposure of skin to UVB radiation induces
infiltration of leukocytes at UVB-irradiated sites in both IL-12
KO and WT mouse skin compared with normal non-UVB-
exposed mouse skin. However, the degree of UVB-induced
infiltration was greater in the skin of IL-12 KO mice than in
their WT counterparts. To confirm whether UVB-induced
infiltration of leukocytes is higher in IL-12 KO mice than WT
mice, we determined the myeloperoxidase (MPO) activity in
the cytosolic fractions of the skin in different treatment groups.
MPO is commonly used as a marker of infiltrating leukocytes
(monocytes/macrophages and neutrophils) in UVB-irradiated
skin. We found a significant increase in MPO activity in the
skin samples of both IL-12 KO (237%, Po0.001) and WT
(93%, Po0.01) mice exposed to UVB radiation compared
with the skin samples of non-UVB-exposed mice; however,
the levels of MPO were significantly higher (Po0.01) in the
skin samples of IL-12 KO mice than in their WT counterparts
(Figure 1c). The increase in MPO activity after UVB exposure
indicates an influx of leukocytes into the inflamed skin.
IL-12-deficient mice express higher levels of protein and mRNA
of PCNA in epidermal cells
We determined the proliferation potential of epidermal cells
(that is, hyperplastic response) as another marker of the UVB-
induced inflammatory reaction in the skin. For this purpose,
the levels of proliferating cell-nuclear antigen (PCNA) were
determined by immunohistochemical detection of PCNAþ
cells, western blotting, and mRNA expression by real-time
PCR. As shown in Figure 2a, the immunostaining pattern of
PCNAþ cells in UVB-exposed skin was more intense in both
IL-12 KO and WT mice as compared with non-UVB-
irradiated mouse skin. However, the size of the cellular
nuclei in the IL-12 KO mice appeared larger and the intensity
of staining was higher in UVB-exposed skin of IL-12 KO mice
than UVB-exposed skin of WT mice, suggesting higher
proliferating potential of epidermal cells in IL-12 KO mice
skin after UVB irradiation. This observation was further
confirmed by western blot analysis (protein level) and real-
time PCR (mRNA expression), which revealed that the levels
of PCNA were higher in UVB-irradiated mouse skin than non-
UVB-irradiated mouse skin, and that levels of PCNA in the
UVB-exposed IL-12 KO mouse skin was greater than in
the UVB-exposed WT mouse skin (Figure 2b).
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Figure 1. IL-12 deficiency enhances skin tumor development and cutaneous
infiltration. (a) IL-12 KO mice develop a higher number of UVB-induced skin
tumors than WT mice. Mice were exposed to UVB three times/week for 35
weeks and tumor data were recorded on a weekly basis (n¼ 20 per group).
Significant difference versus WTs: zPo0.001 at the termination of the tumor
experiment. (b) Chronic exposure of IL-12 KO mice to UVB results in greater
leukocyte infiltration than observed in UVB-irradiated WT (C3H/HeN) mice
skin. The paraffin-embedded skin samples (5 mm thick) were processed for
routine H&E staining following a standard protocol. Representative examples
of micrographs of H&E staining are shown from experiments conducted using
skin samples and had identical patterns (n¼ 10). (c) MPO was determined as a
marker of UVB-induced tissue infiltration. The levels of UVB-induced MPO
were greater in the skin samples of IL-12 KO mice compared with their WT
counterparts. Data are reported as the mean±SD (n¼ 10). Significant
differences: *Po0.01; zPo0.001. Bar¼ 50mm.
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IL-12 deficiency enhances epidermal COX-2 expression and
PGE2 production in response to chronic UVB exposure
UVB-induced COX-2 expression and a subsequent increase in
the production of PG metabolites in the skin is a characteristic
response of keratinocytes following acute or chronic exposure
to UVB radiation. The increased expression of COX-2 and PG
metabolites has been observed in squamous and basal cell
carcinomas of the skin (Vanderveen et al., 1986; Mukhtar and
Elmets, 1996); therefore, we determined and compared the
levels of COX-2 and PGE2 in the UVB-exposed skin samples
of IL-12 KO and their WT mice. Immunohistochemical
analysis of COX-2 indicated that exposure of the skin to UV
radiation resulted in higher expression of COX-2 in the skin of
both IL-12 KO and their WT counterparts as compared with
non-UVB-exposed mouse skin. Further, careful microscopic
observations revealed that staining was more intense and the
numbers of COX-2-positive cells were higher in the epidermis
of IL-12-deficient mice than in WT mouse skin (Figure 2c).
The expression of COX-2 in IL-12 KO mouse skin was
observed to occur in the form of multiple patches and the
numbers of these COX-2þ cell patches were larger than WT
mice. These data were further confirmed by western blot
analysis, which showed higher expression levels of COX-2
protein in IL-12 KO than WT mouse skin (Figure 2d), and thus
identical with the pattern of COX-2 expression as observed by
immunostaining in both strains of mice.
As increased expression of COX-2 results in formation of
greater amounts of PG metabolites, we examined the levels of
PG metabolites in the skin of different treatment groups with
particular emphasis on PGE2 because it appears to be pivotal
in the reciprocal regulation of IL-10 and IL-12 production in
addition to its role in tumor promotion. As shown in Figure
2e, levels of epidermal PGE2 in UVB-irradiated skin were
significantly higher in both IL-12 KO and WT mouse skin
(Po0.001) as compared with non-UVB-exposed epidermis.
Further, levels of PGE2 were significantly higher in the UVB-
exposed epidermis of IL-12 KO mice (Po0.01) than the
epidermis of WT mice.
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Figure 2. IL-12 deficiency enhances the proliferation index potential of epidermal cells and COX-2 expression in UV-exposed skin. (a) Immunohistochemical
analysis of PCNAþ cells in chronic UV-exposed IL-12 KO and WT mouse skin. PCNA staining was more intense in IL-12 KO mice than in their WT
counterparts. (b) The levels of PCNA were determined employing western blot analysis and real-time PCR. The mRNA expression of PCNA is presented after
normalization to b-actin using the Ct method. (c) Immunohistochemical detection and localization of COX-2 expression in skin samples. The UVB-irradiated
skin expressed higher levels of epidermal COX-2 compared with normal skin, and the skin of IL-12 KO mice expressed more intense staining pattern of COX-2
after UVB exposure than WT counterparts. (d) Epidermal COX-2 expression analysis using western blotting, as described under Materials and Methods. In
western blot analysis, a representative blot is shown from three independent experiments with identical observations. In each experiment, the epidermis was
pooled from 2–3 mice for preparing lysate samples, and equivalent protein loading was confirmed by probing stripped blots for b-actin as shown. (e) PGE2 was
determined in the epidermal homogenate samples by an ELISA. The levels of PGE2 were higher in the skin samples of IL-12 KO mice compared with that in WT
mice. The concentration of PGE2 is expressed in terms of pgmg
1 protein as a mean±SD (n¼10). Significant difference versus WTs: *Po0.01. Significant
difference versus normal skin: zPo0.001. Bar¼ 50mm.
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The levels of proinflammatory cytokines were higher in
UVB-irradiated IL-12-deficient mouse skin than in WT mouse
It is well known that exposure of skin to UVB radiation
induces inflammatory responses, including induction of pro-
inflammatory cytokines, and these responses are further
enhanced by UVB-induced infiltrating leukocytes at the
UVB-irradiated site of the skin. Therefore, we examined
and compared the effects of chronic UVB exposure on the
secretion of proinflammatory cytokines in both IL-12 KO and
WT counterparts. Skin samples were used to analyze the
levels of tumor-necrosis factor-a (TNF-a), IL-1b, IL-6, and
IL-10 using ELISA kits following the manufacturer’s protocol.
As shown in Figure 3, chronic exposure of the skin to
UVB radiation resulted in significantly higher synthesis or
accumulation of TNF-a (Po0.001), IL-1b (Po0.01), IL-6
(Po0.01–Po0.001), and IL-10 (Po0.01–0.001) cytokines in
both IL-12 KO and WT mouse skin compared with non-UVB-
exposed control mice. However, levels of these cytokines
were significantly higher (Po0.05–0.01) in the UVB-irra-
diated skin of IL-12 KO mice than UVB-irradiated WT mice.
In vivo subcutaneous treatment of IL-12 KO mice with
rIL-12 results in decreased UVB-induced inflammatory
responses and/or mediators
To verify whether IL-12-deficiency contributes to the UVB-
induced inflammatory responses and their mediators in the
skin, an additional experiment was conducted using IL-12
KO mice. To mimic the effect of chronic UV exposure of the
skin, IL-12 KO mice were UV irradiated on alternate days for
10 days. One group of mice was treated with recombinant IL-
12 (rIL-12) via subcutaneous (s.c.) route before each exposure
to UV. Mice were killed at different time points (6, 12, 24, 48,
and 72 hours) after the last UV exposure, and skin samples
were collected and analyzed for various biomarkers using
immunohistochemistry, biochemical assays, and western blot
analysis. The resultant data were compared between IL-12
KO mice that were treated with rIL-12 or the vehicle only. As
shown in Figure 4a, MPO activity remained higher at all the
time points because of chronic exposure of the skin to UV
radiation as compared with non-UV-exposed control mice.
However, levels of MPO were comparatively higher at 24
and 48 hours after the last UV irradiation of the skin, and
declined thereafter. Treatment of mice with rIL-12 signifi-
cantly inhibited (Po0.01–Po0.001) UV-induced elevated
levels of MPO at all the time points, indicating inhibition of
infiltrating leukocytes after UV exposure of the mouse skin.
As the level of MPO activity was higher at 24 hours after UV
irradiation, we also checked and verified the levels of UV-
induced tissue infiltration histologically by hematoxylin and
eosin (H&E) staining. As shown in Figure 4b (left panels), UV-
induced infiltration was reduced in mice, which were treated
with rIL-12 as compared with in non-rIL-12-treated UV-
exposed mice. The levels of UV-induced PCNA, a marker of
cellular proliferation, were decreased by rIL-12 treatment at
all the time points studied, compared with non-rIL-12-treated
IL-12 KO mouse skin, as evident by western blot analysis
(Figure 4c), and subsequently verified by immunostaining at
24 hours after the last UV exposure (Figure 4b, middle
panels). The levels of the UV-induced metabolite PGE2 also
were checked, and it was observed that the levels of PGE2 in
IL-12 KO mice remained higher at all the time points studied
as compared with that in non-UV-exposed control IL-12 KO
mice; however, s.c. administration of rIL-12 to mouse skin
resulted in significant reduction in the levels of PGE2
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Figure 3. Chronic exposure of UVB produced relatively higher levels of
proinflammatory cytokines in the skin of IL-12 KO mice than UVB exposure
of the WT counterparts. At termination of the experiment, epidermal
homogenates were prepared for analysis of the levels of TNF-a, IL-1b, IL-6,
and IL-10 using ELISA. Significant increases in the levels of these cytokines
were observed after UVB irradiation compared with non-UVB-exposed
animals. The skin samples of IL-12 KO mice were found to have higher levels
of these cytokines over WT mice. The concentration of each cytokine is
reported in terms of pgmg1 protein as a mean±SD (n¼ 8–10). Significant
increases in IL-1b (wPo0.05), TNF-a (*Po0.01), IL-6 (*Po0.01), and IL-10
(wPo0.05) in UVB-exposed IL-12 KO versus UVB-exposed WTs were seen.
Significant difference versus non-UVB-irradiated control skin samples:
zPo0.001; *Po0.01.
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(Po0.01–Po0.001) at all the time points studied (Figure 4d),
as compared with that in non-rIL-12 KO-treated mice. This
was further verified by immunostaining of COX-2 enzyme
expression (Figure 4b, right panels). Again, as levels of PGE2
were higher at 24 hours after the last UV exposure, COX-2
immunostaining was performed at this time point, and it was
observed that treatment with rIL-12 resulted in a reduction in
UV-induced COX-2 expression in IL-12 KO mice. The
kinetics of these data support the concept that IL-12
deficiency exacerbates UVB-induced inflammatory responses
and the mediators of these responses.
The susceptibility of IL-12 KO mice to UV-induced
inflammation and tumorigenesis is linked to their deficiency in
the repair of UV-induced DNA damage
In this study, we found that IL-12 deficiency exacerbates
inflammatory responses in UV-irradiated skin (Figures 2–4),
and also enhances skin tumor development (Figure 1a;
Meeran et al., 2006). As UV-induced inflammatory responses
and UV-induced tumorigenesis are both causally related to
UV-induced DNA damage, we examined whether IL-12 KO
mice are more susceptible to the adverse effects of UV as they
are deficient in the repair of UV-induced DNA damage.
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Figure 4. In vivo s.c. treatment of IL-12 KO mice with rIL-12 inhibits multiple UVB exposure-induced leukocyte infiltration, the levels of MPO, COX-2, PGE2,
and PCNA compared with non-rIL-12-treated IL-12 KO mice. Mice were UVB-irradiated (180mJ cm2) on alternate days for total 10 days. One group of mice
was injected via s.c. route with murine IL-12 (50 ng per mouse) 3 hours before each exposure of UVB. Mice were killed at different time points (6, 12, 24, 48, and
72hours) after the last UVB exposure, and skin samples were obtained and analyzed for MPO, infiltration, PCNA, COX-2, and PGE2 as described under
Materials and Methods. Data were analyzed using biochemical assays for MPO and PGE2 (a, d); immunohistochemistry for infiltration, PCNA, and COX-2 (b);
and western blot analysis for PCNA (c). Epidermal lysates were used for western blot analysis and equivalent protein loading was confirmed by probing stripped
blots for b-actin as shown. A representative blot is shown from three independent experiments with identical observations; n¼ 3 at each time point studied.
(d) PGE2 was determined in the skin samples by an ELISA. Significant inhibition in rIL-12-treated mice versus non-rIL-12-treated but UV-exposed mice:
*Po0.01; zPo0.001. Bar¼ 50 mm.
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Additional experiments were, therefore, conducted to exam-
ine this aspect of UV-induced damage. IL-12 KO mice and
their WT counterparts were exposed to either acute
(180mJ cm2) or multiple UV exposures on alternate days
for 10 days. Mice were killed at different time points (for
example, immediately (within 30minutes), 24, 48, and
72 hours) after the last UV exposure. Skin samples were
collected and subjected to analysis of CPDs as a marker of
DNA damage, and PGE2, TNF-a, and IL-1b as markers of
inflammation. Frozen skin sections (5 mm thick) were
subjected to immunohistochemical detection of CPDþ cells
using an antibody directed against CPD (Kamiya Biomedical
Co., Seattle, WA). In skin samples obtained immediately after
UV exposure, no differences in the staining pattern of CPDs
were observed between IL-12 KO and WT mice (Figure 5a).
Also, DNA repair in both WT and IL-12 KO mice was not
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Figure 5. UV-induced CPDs are removed or repaired rapidly in WT mice than in IL-12 KO mice, and treatment of s.c. rIL-12 to IL-12 KO mice before UV
irradiation removes or repairs UV-induced CPDs rapidly than IL-12 KO mice, which were not treated with rIL-12. Mice were exposed to either acute (a–c) or
multiple UV (180mJ cm2) exposure (d–f). In multiple UV exposure, mice were exposed to UV on alternate days for 10 days. One group of mice was injected
with murine rIL-12 (50 ng per mouse) via s.c. route, 3 hours before exposure of UV. Mice were killed at different time points (1/2, 48, and 72 hours) after the
last UVB exposure, and skin samples were obtained and analyzed for CPDs using immunohistochemistry and dot-blot analysis. Frozen sections (5 mm thick)
were subjected to immunoperoxidase staining to detect CPDþ cells that are dark brown. CPDs were not detected in non-UV-exposed skin whether treated
or not treated with rIL-12. Epidermal PGE2 was determined as a marker of inflammation using immunoassay kit (c, f), as describes under Materials and methods.
(e) Epidermal genomic DNA was subjected to Southwestern dot blot analysis to detect UV-induced damaged DNA using an antibody specific to CPD.
(f) Inflammatory cytokines TNF-a and IL-1b were determined in epidermal homogenates using ELISA kits. Experiments were conducted and repeated separately
in 5–6 animals in each group with identical results. Results are expressed as mean±SD. Significantly less than IL-12 KO mice: *Po0.01; zPo0.001.
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significant at 24 hours after UV exposure compared with
samples collected immediately after UV exposure (data not
shown). However, in samples obtained at 48 and 72 hours
after UVB exposure, the numbers of CPDþ cells were
significantly less (Po0.01–0.001) in the WT mice compared
with the number of CPDþ cells obtained immediately after
UV exposure of WT mice. As anticipated, the number of
CPDþ cells in IL-12 KO mice at 48 and 72 hours after UVB
exposure had decreased, but this decrease was not signifi-
cantly different as from the number of CPDþ cells detected
immediately after UV exposure. Moreover, spontaneous
DNA repair was greater in WT mice than in IL-12 KO mice
as shown in Figure 5a, with data being summarized in Figure
5b. This suggests that the difference in DNA repair between
WT and IL-12 KO may be due to the absence of IL-12 in IL-12
KO mice. Further, s.c. injection of rIL-12 to IL-12 KO mice at
UV-irradiated skin sites resulted in rapid repair or removal of
CPDþ cells, suggesting that IL-12 is required for enhancing
repair of UV-induced DNA damage in the form of CPDs. We
also determined the levels of epidermal PGE2 in the same
skin samples and found that the levels of PGE2 were higher at
48 and 72 hours after UV exposure in the skin samples of
IL-12 KO mice than WT mice (Figure 5c). Treatment of IL-12
KO mice with rIL-12 resulted in reduction of PGE2 (37–50%,
Po0.01) concomitant with enhanced repair of UV-induced
DNA damage. The skin samples obtained from the groups of
mice that were not exposed to UV (normal skin) were devoid
of CPDþ cells.
Further, the effect of multiple UV irradiation of the mouse
skin was determined in terms of UV-induced DNA damage in
the form of CPDs and inflammatory responses in both IL-12
KO and WT mice. As for analysis of acute UV exposure, mice
were killed after the last UV exposure either immediately
(within 30minutes) or at 24, 48, and 72 hours, and skin
samples were collected. Immunohistochemical analysis of
CPDs was performed and resultant data are summarized in
terms of per cent CPDþ cells in different treatment groups as
shown in Figure 5d. Overall, the repair rate of UVB-induced
CPDs was lower in skin samples from mice that
were subjected to multiple UV exposures as compared
with samples from mice that were subjected to single
UV exposure. We could not detect repair or removal of
UVB-induced CPDþ cells until 24 hours after the last
UV exposure; however, the number of CPDþ cells was
significantly decreased or repaired in WT mice at 72 hours
after UV exposure compared with the number of CPDþ cells
in the skin samples obtained immediately after UV exposure
(Po0.001). The repair kinetics of the CPDþ cells in IL-12 KO
mice that had been subjected to multiple UV exposures were
not significant and were slower than that in WT mice (Figure
5d). In vivo s.c. treatment of rIL-12 to IL-12 KO mice resulted
in more rapid removal or repair of UV-induced CPDþ cells
than in IL-12 KO mice that were not treated with rIL-12,
indicating that repair of UV-induced DNA damage requires
IL-12. Further, the effect of UV-induced DNA damage in the
form of CPDs was checked and confirmed by Southwestern
dot-blot analysis. Epidermal genomic DNA from the skin
samples of different treatment groups was isolated and
subjected to dot-blot analysis (Figure 5e). It was observed
that UV-induced DNA damage was repaired or removed
rapidly in WT mouse skin than IL-12 KO mice, and that
treatment with rIL-12 to IL-12 KO mice enhances repair of
UV-induced DNA damage in the form of CPDs as indicated
by the intensity of dot-blots (Figure 5e). To correlate the effect
of UV-induced DNA damage with induction of inflammation
in the mouse skin, we determined the levels of PGE2, TNF-a,
and IL-1b, as markers of inflammation, in the same skin
samples. As shown in Figure 5f, levels of PGE2, TNF-a, and
IL-1b were significantly higher in the UV-exposed skin of
IL-12 KO mice as compared with the skin samples of WT
mice. As can be seen in Figure 5d and f, the significant
reduction in the numbers of CPDþ cells in WT mice
particularly at 72 hours after UV exposure also resulted in
significant reduction in the levels of PGE2, TNF-a, and IL-1b
in WT mice as compared with that in IL-12 KO mice. A
similar pattern was observed in IL-12 KO mice, which were
treated with rIL-12 via s.c.route.
UVB-induced skin tumors of IL-12 KO mice express higher
levels of PCNA, cyclin-D1, COX-2, PGE2 metabolite, and
proinflammatory cytokines than those of WT mice
After determining the status of UVB-induced inflammation
and their mediators in the skin of IL-12 KO and their WT
mice, we further checked the status of these biomarkers of
inflammatory reactions in skin tumors. The UVB-induced skin
tumors were subjected to analysis of PCNA and COX-2
expression using immunostaining, western blot analysis, and
mRNA expression. Immunostaining analyses clearly indi-
cated that levels of PCNA and COX-2 were higher in terms
of intense staining pattern and the number of positive cells
in the tumors of IL-12 KO mice as compared with those of
WT mice (Figure 6a and b). This observation was further
confirmed by checking the status of PCNA and COX-2
proteins in the tumor lysate samples using western blot
analysis. The intensities of the bands in western blot analysis
indicated that the protein levels of PCNA and COX-2 were
relatively higher in the tumors of IL-12 KO mice than in those
of WT mice (Figure 6a and b). The levels of cyclin-D1,
another marker of cellular proliferation, were also higher in
the tumors of IL-12 KO mice than in those of WT mice (Figure
6a). Analysis of b-actin confirmed equal loading of samples.
Further, the mRNA expression levels of PCNA and cyclin-D1
were also checked and verified through analysis of their
mRNA levels in tumor samples of IL-12 KO and WT mice. It
was observed that the mRNA expression levels of PCNA and
cyclin-D1 were significantly higher (Po0.01) in the tumors of
IL-12 KO mice than in those of WT mice (Figure 6a).
Additionally, we determined the levels of PGE2 in these
tumor samples, as this is an important PG metabolite that
plays a crucial role in tumor promotion. As shown in Figure
6b, the concentration of PGE2 in the tumors of IL-12 KO mice
was significantly higher (59%, Po0.01) than in those of
WT mice. Similarly, the levels of proinflammatory cytokines,
such as TNF-a and IL-1b, were also higher (Po0.01) in the
tumors of IL-12 KO mice compared with those of WT mice
(Figure 6c).
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DISCUSSION
Chronic exposure of the skin to solar UV radiation is
considered a major etiologic factor for development of skin
cancers. In addition to other adverse effects of UV radiation,
UV-induced inflammation and their mediators are considered
potent regulators of tumor promotion in melanoma and non-
melanoma skin cancers. We have shown that deficiency of
IL-12 promotes photocarcinogenesis in mouse skin. We were
interested to see whether deficiency of IL-12 in mice
exacerbates UVB-induced inflammatory responses that are
the contributing factor in the development of skin tumors in
UV-exposed skin. We observed that the influx of UV-induced
inflammatory infiltrating cells in IL-12 KO mouse skin was
higher than in their WT counterparts. These infiltrating
leukocytes produce proinflammatory cytokines, which sti-
mulate adverse effects in the skin, including stimulation of
hyperproliferation and genetic mutation in epidermal cells.
One of the most important enzymes in the process of
inflammation and cancer development is inducible COX-2.
COX-2 is a rate-limiting enzyme for generation of PG
metabolites from arachidonic acids (Langenbach et al.,
1999). COX-2 overexpression has been linked to the
pathophysiology of inflammation and cancer (Chapple
et al., 2000) due to enhanced synthesis of PG metabolites,
which have been shown to be potential contributing factor in
UV-induced non-melanoma skin cancers (Marks et al., 1999;
Williams et al., 1999). A number of studies have demon-
strated overexpression of COX-2 in chronically UVB-irra-
diated skin, as well as in UVB-induced premalignant lesions
and squamous cell carcinomas (Buckman et al., 1998; Athar
et al., 2001). A role of COX-2 in photocarcinogenesis is also
supported by several studies demonstrating that inhibition of
COX-2 activity by specific inhibitors can partially block
carcinogenesis induced by long-term UVB exposure (Pent-
land et al., 1999; Wilgus et al., 2003). The induction of COX-
2 enhances formation of PG metabolites, wherein PGE2 is a
potential mediator of inflammatory reactions. In this study,
we found that IL-12 KO mice expressed higher levels of COX-
2 expression and greater production of PGE2, which may
have contributed to rapid tumor development in IL-12 KO
mice as compared with that in their WT counterparts. The
increased proliferating potential of epidermal keratinocytes,
which is indicated by the higher expression of the protein and
mRNA of PCNA, may also be a contributing factor for the
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Figure 6. UV-induced skin tumors of IL-12 KO mice express higher levels of inflammatory responses than wild-types. The UV-induced tumors developed in
IL-12 KO mice expressed higher levels of inflammatory mediators such as, PCNA, cyclin-D1 (a), COX-2, and PGE2 (b), and inflammatory cytokines, TNF-a and
IL-1b (c), compared with WT mice. The expression levels of PCNA and COX-2 were determined by immunostaining, western blot analysis, and/or real-time
PCR. Representative example of micrographs of staining for PCNA and COX-2 was presented from at least six mice, which showed identical patterns.
Bar¼50 mm. The representative blots are shown from three independent experiments, and in each experiment the tumor samples were pooled from at least three
mice. The results of mRNA expression of PCNA and cyclin-D1 are presented after normalization to b-actin using the Ct method. The levels of PGE2, TNF-a and
IL-1b were determined in tumor homogenates using ELISA kits and data are presented as mean±SD in terms of pgmg1 protein. Experiments were repeated in
tumor samples from at least six mice with identical results. *Significant difference versus WT: Po0.01.
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more rapid development of tumors in UV-exposed IL-12 KO
mice as compared with that than their WT counterparts.
Further, levels of proinflammatory cytokines like TNF-a,
IL-1b, and IL-6 were higher in UVB-exposed skin of IL-12 KO
mice than WT mice. The higher levels of these inflammatory
cytokines may contribute to the tumor-promotion process and
thus development of tumors may occur earlier and more
rapidly in UV-exposed skin. This trend was observed in IL-12
KO mice in which development of UVB-induced skin tumors
occurred earlier and their growth was more rapid than in their
WT counterparts (Figure 1a; Meeran et al., 2006). These data
suggest a positive relationship between UVB-induced inflam-
mation and UVB-induced increases in skin tumorigenesis in
IL-12 KO mice. Further, COX-2-induced PGE2 has been
shown to be a potent inhibitor of IL-12. Thus, in the absence
of IL-12, or at low levels of this cytokine, the risk of UV-
induced skin tumors will increase. The higher levels of
proinflammatory cytokines have been implicated in skin
cancer risk (Tron et al., 1988; Mukhtar and Elmets, 1996; Scott
et al., 2003). Proinflammatory cytokines can induce COX-2
expression (Pang and Knox, 1997), and this in turn may
increase production of PG metabolites, which would stimu-
late tumor development. The trends of different inflammatory
biomarkers observed in UVB-exposed skin were further
checked in skin tumors, and it was observed that the levels
of these biomarkers of inflammation and their mediators (for
example, PCNA, COX-2, PGE2, cyclin-D1, TNF-a, and IL-1b)
were higher in the tumors of IL-12 KO mice as compared with
those of their WT counterparts. Thus, these findings suggest
that IL-12 deficiency exacerbates UVB-induced inflammatory
responses in mouse skin and this may be a contributing factor
for the early, rapid, and enhanced development of skin tumors
in UVB-exposed skin of IL-12 KO mice.
UVB-induced inflammatory responses, such as production
of cytokines, and UVB-induced tumorigenesis are both
causally related to UVB-induced DNA damage. Therefore,
further experiments were conducted in IL-12-deficient mice
and their WT counterparts to demonstrate the effect of IL-12
on UV-induced DNA damage and its relationship with the
development of skin inflammation in our model. Following
acute and chronic UV exposure, it was observed that UV-
induced DNA damage in the form of CPDs was repaired or
removed more rapidly in WT mice than in IL-12 KO mice.
The role of IL-12 in DNA repair was further supported by data
obtained after s.c. injection of the rIL-12 to the UV-irradiated
skin site of IL-12 KO mice. Injection of IL-12 to IL-12 KO
mice removed or repaired UV-induced CPDs more rapidly
than in non-rIL-12-treated IL-12 KO mice. These data support
the concept that removal or repair of UV-induced DNA
damage in the form of CPDs requires IL-12. Our findings are
supported by the observations of Schwarz et al. (2002) who
reported that IL-12 reduces or repairs UV-induced DNA
damage in vitro and in vivo mouse skin, and that this repair is
mediated through a nucleotide excision repair mechanism.
Importantly, levels of inflammatory biomarkers, such as
PGE2, TNF-a, and IL-1b, were also elevated when levels of
UV-induced DNA damage were higher and reduced subse-
quently when levels of DNA damage was decreased. These
information support the evidence that UV-induced DNA
damage and inflammatory responses are causally related with
increased risk of photocarcinogenesis. The outcome of this
study, therefore, suggests that endogenous enhancement of
IL-12 levels may be considered an effective strategy in the
prevention and treatment of UV-induced skin cancers.
MATERIALS AND METHODS
Animals, antibodies, chemicals, and real-time-PCR primers
Pathogen-free female C3H/HeN mice (6–7 weeks old) were
purchased from Charles River Laboratory (Wilmington, MA). The
IL-12 KO mice on C3H/HeN background were generated in our
Animal Resource Facility as described previously (Meeran et al.,
2006). The mutation in the IL-12p35 chain in IL-12 KO mice
completely eliminates synthesis of biologically active IL-12 protein
in these mice. All mice were maintained under standard 12-hour
dark/12-hour light cycle, 24±2 1C temperature and 50±10%
relative humidity.
The endotoxin-free mouse rIL-12 was purchased from
eBioscience (San Diego, CA). Immunostaining-specific COX-2
antibody and a kit for PGE2 analysis were obtained from Cayman
Chemicals (Ann Arbor, MI). The antibodies for PCNA, cyclin-D1,
and their secondary antibodies were obtained from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA). The enhanced chemilumines-
cence detection reagents for western blotting were purchased from
Amersham Pharmacia Biotech (Piscataway, NJ). ELISA kits specific
for mouse TNF-a, IL-1b, IL-6, and IL-10 were obtained from
BioSource International (Camarillo, CA). The manufacturer-supplied
standardized real-time PCR primer pairs for the PCNA, cyclin-D1,
and b-actin were obtained from the SuperArray Bioscience
Corporation (Frederick, MD). Trypsin, DNase, and all other
chemicals were purchased from Sigma Chemical Co. (St Louis, MO).
UVB exposure of mice
Briefly, clipper-shaved and chemically depilated dorsal skin was
exposed to UVB radiation (180mJ cm2) from a band of four FS24T1
UVB lamps (Daavlin; UVA/UVB Research Irradiation Unit, Bryan,
OH) equipped with an electronic controller to regulate UV dosage.
The UVB lamps primarily emit UVB (290–320 nm, 480% of total
energy) and UVA (320–375 nm, o20% of total energy) radiation,
with peak emission at 314 nm as monitored (Meeran et al., 2006).
Studies were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of Alabama at Birmingham.
Photocarcinogenesis protocol
A photocarcinogenesis experiment was performed using IL-12 KO mice
and their WT counterparts (C3H/HeN), as described previously (Meeran
et al., 2006). Briefly, mice were exposed to UVB (180mJ cm2) three
times/week until tumor yield was stabilized, that is, 35 weeks. When
tumor yield and growth stabilized, the photocarcinogenesis experiment
was terminated and skin and tumor samples were collected for analysis
of various biomarkers of inflammation. Control groups of mice, which
were age- and sex-matched with the experimental groups, were not
exposed to UVB (n¼ 20 per group).
In vivo treatment with recombinant IL-12
To verify whether IL-12 deficiency stimulates inflammation in
UV-exposed skin, IL-12 KO mice were treated via s.c. route with
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endotoxin-free murine rIL-12 (50 ng per mouse per 100ml phos-
phate-buffered saline (PBS); eBioscience) on the shaved back of
the mice at least 3 hours before UVB exposure (180mJ cm2). Mice
were exposed to UVB on alternate days for total 10 days, and killed
at the different time points after the last UVB exposure. The skin
samples were collected for analysis of different biomarkers. Control
mice were injected with 100 ml of sterile saline via s.c. route before
each UVB irradiation.
Histological evaluation for infiltrating leukocytes
Skin samples were fixed in 10% buffered formalin and processed for
routine H&E staining for detecting infiltrating cells microscopically.
MPO assay
MPO activity was determined as a marker of tissue infiltration
following the procedure of Bradley et al. (1982) and as modified by
us (Katiyar et al., 1999a, b). Briefly, skin samples were homogenized
in 50mM potassium phosphate buffer, pH 6, containing 0.5%
hexadecyltrimethylammonium bromide, followed by sonication of
the homogenate at 4 1C for three 10-second bursts with a heat system
sonicator equipped with a microprobe. The tissue homogenate thus
obtained was centrifuged and the resulting supernatants were used
for MPO estimation. MPO activity in the supernatant (0.1ml)
was assayed by mixing with 50mM phosphate buffer (2.9ml),
pH 6, containing 0.167mgml o-dianisidine dihydrochloride and
0.0005% hydrogen peroxide. The change in absorbance resulting
from decomposition of H2O2 in the presence of o-dianisidine was
measured at 460 nm using a Beckman Coulter DU 530 spectro-
photometer. The data are expressed as mean MPO units per mg
protein.
Immunohistochemical detection of COX-2 and PCNA
Five 5mm thick sections were deparaffinized and rehydrated in a
graded series of alcohols. Following rehydration, an antigen retrieval
process was performed by placing the slides in 10mM sodium citrate
buffer, pH 6, at 95 1C for 20minutes followed by a 20-minute
cooling step. The sections were washed in PBS and nonspecific
binding sites were blocked with 1% BSA with 2% goat serum in PBS.
The sections were incubated with an anti-COX-2 or anti-PCNA
antibody for 2 hours at room temperature. The sections were washed
and incubated with biotinylated secondary antibody for 45minutes,
followed by treatment with horseradish peroxidase-conjugated
streptavidin. After washing in PBS, sections were incubated with
diaminobenzidine substrate and counterstained with HE. Represen-
tative images were taken using Nikon Eclipse E400 inverted
microscope and DXM1200 digital camera.
Immunohistochemical detection of CPDs
Immunohistochemical analysis was performed to detect CPDþ cells
in the skin samples, using a procedure described previously (Katiyar
et al., 2000). Briefly, 5-mm-thick frozen skin sections were thawed
and kept in 70mM NaOH in 70% ethanol for 2minutes to denature
nuclear DNA, followed by neutralization for 1minute in 100mM
Tris-HCl (pH 7.5) in 70% ethanol. The sections were washed with
PBS buffer and incubated with 10% goat serum in PBS to prevent
nonspecific binding prior to incubation with a monoclonal antibody
specific for CPDs or its isotype control (IgG1). Bound anti-CPD
antibody was detected by incubation with biotinylated goat
anti-mouse IgG1 followed by treatment with peroxidase-labeled
streptavidin. After washing, sections were incubated with diamino-
benzidine and counterstained with H&E.
Southwestern dot-blot analysis
Genomic DNA from epidermal skin or tumor samples was isolated
following the standard procedures and dot-blot analysis was
performed as detailed previously (Meeran et al., 2006). Genomic
DNA (500 ng) was transferred to a positively charged nitrocellulose
membrane by vacuum dot-blotting (Bio-Dot Apparatus; Bio-Rad,
Hercules, CA) and fixed by baking the membrane for 30minutes at
80 1C. After blocking nonspecific binding sites in blocking buffer
(5% non-fat dry milk, 1% Tween-20 in 20mM TBS, pH 7.6), the
membrane was incubated with the antibody specific to CPDs for
1 hour at room temperature. After washing, the membrane was
incubated with horseradish peroxidase-conjugated secondary anti-
body. The circular bands of CPDs were detected by chemilumines-
cence using the enhanced chemiluminescence detection system.
The genomic DNA was used and tested from at least five mice in
each group independently.
PGE2 by enzyme immunoassay
Skin or tumor samples were homogenized in 100mM phosphate
buffer, pH 7.4, containing 1mM EDTA and 10 mM indomethacin
using polytron homogenizer (PT3100; Fisher Scientific, Pittsburg,
PA). The supernatants were collected and the concentration of PGE2
was determined in supernatants using the Cayman PGE2 enzyme
immunoassay kit (Cayman Chemical) following the manufacturer’s
protocol.
Preparation of skin and tumor lysates for western blotting
Skin (epidermis) or tumor lysates for western blot analysis were
prepared as described previously (Roy et al., 2005). The epidermis
was separated from the whole skin as described earlier (Katiyar et al.,
1999a, b). The epidermis or tumor tissue samples were pooled from
at least two mice in each group, and five sets of pooled samples from
each treatment group were used to prepare lysates, thus yielding
10 samples for analysis. Proteins (25–50 mg) were resolved on
12% Tris-glycine gel and transferred onto nitrocellulose membranes.
Membranes were incubated in blocking buffer for 1 hour at room
temperature and then incubated with the primary antibodies in
blocking buffer overnight at 4 1C. The membrane was then washed
with PBS and incubated with horseradish peroxidase-conjugated
secondary antibody. Protein bands were visualized using the
enhanced chemiluminescence detection reagents. To verify equal
protein loading and transfer of proteins from gel to membrane, the
blots were stripped and reprobed for b-actin using an anti-actin
rabbit polyclonal antibody.
RNA extraction and quantitative real-time PCR
Total RNA was extracted from mouse epidermis or tumor samples
using TRIzol reagent (Invitrogen, Carlsbad, CA) following the
protocol recommended by the manufacturer. The concentration of
total RNA was determined by measuring the optical density at
260 nm using Beckman/Coulter DU 530 spectrophotometer. The
mRNA expression of PCNA and cyclin-D1 in skin and tumor
samples was determined using real-time PCR. For mRNA quantifica-
tion, cDNA was synthesized using 3 mg of RNA through a reverse
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transcription reaction (iScript cDNA Synthesis kit; Bio-Rad). Using
SYBR Green/Fluorescein PCR Master Mix (SuperArray Bioscience
Corporation), cDNA was amplified using real-time PCR with a
BioRad MyiQ thermocycler and SYBR green detection system
(Bio-Rad). Samples were run in triplicate to ensure amplification
integrity. Manufacturer-supplied (SuperArray Bioscience Corpora-
tion) primer pairs were used to measure the following: PCNA (cat.
no. PPM03456E) and cycline-D1 (cat. no. PPM02903E). The
standard PCR conditions were as follows: 95 1C for 15minutes, then
40 cycles at 95 1C for 30 seconds; 55 1C for 30 s; and 72 1C at 30 s, as
recommended by the primer’s manufacturer. The expression levels
of the genes were normalized to that of the b-actin mRNA in each
sample. The threshold for positivity of real-time PCR was determined
based on negative controls. For mRNA analysis, calculations for
determining the relative level of gene expression were made using
the cycle threshold (Ct) method. The mean Ct values from duplicate
measurements were used to calculate the expression of the target
gene with normalization to a housekeeping gene used as internal
control (b-actin), and using 2DC t method.
Cytokine assay by ELISA
Epidermal homogenates from each treatment group were used for
analysis of cytokines, such as, TNF-a, IL-1b, IL-6, and IL-10, using
ELISA kits (BioSource International) following the manufacturer’s
protocol.
Statistical analysis
The results of the cytokines level, MPO, PGE2, and CPDs are
expressed as means±SD. The statistical significance of difference
between the values of control and treatment groups was determined
by analysis of variance followed by post hoc test. A P-value o0.05
was considered statistically significant.
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